Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells

Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmeier, Beatrice, Fichtner, Iduna, Killian, Peter H., Kronski, Emanuel, Pfeffer, Ulrich, Efferth, Thomas
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102747/
https://www.ncbi.nlm.nih.gov/pubmed/21637790
http://dx.doi.org/10.1371/journal.pone.0020550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102747/
https://www.ncbi.nlm.nih.gov/pubmed/21637790
http://dx.doi.org/10.1371/journal.pone.0020550

Ejemplares similares